Leukotriene pathway polymorphisms are associated with altered cysteinyl leukotriene production in children with acute asthma

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 1, 2009, Pages 9-15

  Bizzintino, Joelene A ^a   Khoo, Siew Kim ^a   Zhang, Guicheng ^a   Martin, Andrew C ^a   Rueter, Kristina ^b   Geelhoed, Gary C ^b   Goldblatt, Jack ^a   Laing, Ingrid A ^a   Le Souëf, Peter N ^a   Hayden, Catherine M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Acute asthma; Childhood; Leukotriene; Single nucleotide polymorphism

Indexed keywords

ADENINE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CREATININE; CYTOSINE; GENE PRODUCT; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 4; GUANINE; IPRATROPIUM BROMIDE; LEUKOTRIENE C4; LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE; PREDNISOLONE; PROTEIN ALOX5; PROTEIN CYSTLTR1; SALBUTAMOL; THYMIDINE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADOLESCENT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DNA POLYMORPHISM; FATTY ACID SYNTHESIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE DISEASE; ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTEINE; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; LEUKOTRIENE E4; LEUKOTRIENES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LEUKOTRIENE;

EID: 67649449334     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.05.022     Document Type: Article

References (44)

1. Dahlen S.E., Hedqvist P., Hammarstrom S., and Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 288 5790 (1980) 484-486
2. Kanaoka Y., and Boyce J.A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173 3 (2004) 1503-1510
3. Peters-Golden M., Canetti C., Mancuso P., and Coffey M.J. Leukotrienes: underappreciated mediators of innate immune responses. J. Immunol. 174 2 (2005) 589-594
4. Lewis R.A., Austen K.F., and Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323 10 (1990) 645-655
5. Green S.A., Malice M.P., Tanaka W., Tozzi C.A., and Reiss T.F. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax 59 2 (2004) 100-104
6. Oh J.W., Shin S.A., and Lee H.B. Urine leukotriene E and eosinophil cationic protein in nasopharyngeal aspiration from young wheezy children. Pediatr. Allergy Immunol. 16 5 (2005) 416-421
7. Severien C., Artlich A., Jonas S., and Becher G. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma. Eur. Respir. J. 16 4 (2000) 588-592
8. Suzuki N., Hishinuma T., Abe F., et al. Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients. Prostaglandins Other Lipid Mediat. 62 4 (2000) 395-403
9. Kumlin M., Dahlen B., Bjorck T., Zetterstrom O., Granstrom E., and Dahlen S.E. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am. Rev. Respir. Dis. 146 1 (1992) 96-103
10. Kemp J.P. Recent advances in the management of asthma using leukotriene modifiers. Am. J. Respir. Med. 2 2 (2003) 139-156
11. Spahr J.E., and Krawiec M.E. Leukotriene receptor antagonists-risks and benefits for use in paediatric asthma. Expert Opin. Drug Saf. 3 3 (2004) 173-185
12. Misso N.L., Peroni D.J., Watkins D.N., Stewart G.A., and Thompson P.J. Glutathione peroxidase activity and mRNA expression in eosinophils and neutrophils of asthmatic and non-asthmatic subjects. J. Leukoc. Biol. 63 1 (1998) 124-130
13. Lynch K.R., O'Neill G.P., Liu Q., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399 6738 (1999) 789-793
14. Koshino T., Takano S., Kitani S., et al. Novel polymorphism of the 5-lipoxygenase activating protein (FLAP) promoter gene associated with asthma. Mol. Cell Biol. Res. Commun. 2 1 (1999) 32-35
15. Kedda M.A., Shi J., Duffy D., et al. Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma. J. Allergy Clin. Immunol. 113 5 (2004) 889-895
16. Sampson A.P., Siddiqui S., Buchanan D., et al. Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 55 Suppl. 2 (2000) S28-S31
17. Drazen J.M., Yandava C.N., Dube L., et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat. Genet. 22 2 (1999) 168-170
18. Asano K., Shiomi T., Hasegawa N., et al. Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma. Pharmacogenetics 12 7 (2002) 565-570
19. Choi J.H., Park H.S., Oh H.B., et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum. Genet. 114 4 (2004) 337-344
20. Sanak M., Pierzchalska M., Bazan-Socha S., and Szczeklik A. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am. J. Respir. Cell Mol. Biol. 23 3 (2000) 290-296
21. Sanak M., Simon H.U., and Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350 9091 (1997) 1599-1600
22. Villette S., Kyle J.A., Brown K.M., et al. A novel single nucleotide polymorphism in the 3' untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol. Dis. 29 2 (2002) 174-178
23. Inoue R., Fukao T., Kato Y., Teramoto T., Utsumi M., and Kondo N. Time-course study of the levels of urinary leukotriene E4, serum thromboxane B2 and serum eosinophil cationic protein in spontaneous asthma attacks in five children. J. Invest. Allergol. Clin. Immunol. 9 6 (1999) 361-366
24. Sampson A.P., Castling D.P., Green C.P., and Price J.F. Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch. Dis. Child 73 3 (1995) 221-225
25. Kalayci O., Birben E., Sackesen C., et al. ALOX5 promoter genotype, asthma severity and LTC production by eosinophils. Allergy 61 1 (2006) 97-103
26. Sayers I., Barton S., Rorke S., et al. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin. Exp. Allergy 33 8 (2003) 1103-1110
27. In K.H., Asano K., Beier D., et al. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J. Clin. Invest. 99 5 (1997) 1130-1137
28. Sayers I., Barton S., Rorke S., et al. Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. Thorax 58 5 (2003) 417-424
29. Martin A.C., Laing I.A., Khoo S.K., et al. Acute asthma in children: Relationships among CD14 and CC16 genotypes, plasma levels, and severity. Am. J. Respir. Crit. Care Med. 173 6 (2006) 617-622
30. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. Asthma, From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161 5 (2000) 1720-1745
31. Young S., Le Souef P.N., Geelhoed G.C., Stick S.M., Turner K.J., and Landau L.I. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N. Engl. J. Med. 324 17 (1991) 1168-1173
32. Qureshi F., Pestian J., Davis P., and Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N. Engl. J. Med. 339 15 (1998) 1030-1035
33. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 3 (1988) 1215
34. Westcott J.Y., Maxey K.M., MacDonald J., and Wenzel S.E. Immunoaffinity resin for purification of urinary leukotriene E4. Prostaglandins Other Lipid Mediat. 55 5-6 (1998) 301-321
35. Misso N.L., Aggarwal S., Phelps S., Beard R., and Thompson P.J. Urinary leukotriene E4 and 9 alpha, 11 beta-prostaglandin F concentrations in mild, moderate and severe asthma, and in healthy subjects. Clin. Exp. Allergy 34 4 (2004) 624-631
36. Kumlin M., Stensvad F., Larsson L., Dahlen B., and Dahlen S.E. Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans. Clin. Exp. Allergy 25 5 (1995) 467-479
37. Hao L., Sawyers I., Cakebread J.A., Barton S.J., Beghe B., Holgate S.T., and Sampson A.P. J.W. Holloway. The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma. Clin. Exp. Allergy 36 6 (2006) 735-741
38. Arriba-Mendez S., Sanz C., Isidoro-Garcia M., et al. Analysis of 927, T>C CYSLTR1 and -444A >C LTC4S polymorphisms in children with asthma. Allergol. Immunopathol. (Madr.) 36 5 (2008) 259-263
39. Oommen A., and Grigg J. Urinary leukotriene E4 in preschool children with acute clinical viral wheeze. Eur. Respir. J. 21 1 (2003) 149-154
40. Oosaki R., Mizushima Y., Mita H., Shida T., Akiyama K., and Kobayashi M. Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. Allergy 52 4 (1997) 470-473
41. Lima J.J., Zhang S., Grant A., et al. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am. J. Respir. Crit. Care Med. 173 4 (2006) 379-385
42. Klotsman M., York T.P., Pillai S.G., et al. Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast. Pharmacogenet. Genomics 17 3 (2007) 189-196
43. Kawagishi Y., Mita H., Taniguchi M., et al. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J. Allergy Clin. Immunol. 109 6 (2002) 936-942
44. Van Sambeek R., Stevenson D.D., Baldasaro M., et al. 5′ flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J. Allergy Clin. Immunol. 106 1 Pt 1 (2000) 72-76